Glycomics or Glycobiology Market worth 1211.4 Million USD by 2021

Glycomics/Glycobiology Market by Product (Enzymes (Glycosyltransferase, Glycosidase), Instruments (HPLS, Mass Spectrometry, MALDITOF), Kits & Reagents (Glycoproteins)), Application (Diagnostic, Drug Discovery, Oncology), End User - Global Forecast to 2021 ¬†The global glycomics/glycobiology market is expected to reach USD 1,211.4 Million by 2021 from USD 649.5 Million in 2016, at a CAGR of 13.3% during the forecast … Continue reading Glycomics or Glycobiology Market worth 1211.4 Million USD by 2021

Advertisements

Mycoplasma Testing Market by Product & Services, Technique, Application and End User – 2022

Factors driving the growth of this market are the rapid growth in the pharmaceutical and biotechnology industries, R&D investments and government support. Mycoplasma testing is carried out in the research and production of all biopharmaceutical products. Growth in the pharmaceutical and biotechnology sector across the globe serves as a direct driver for associated markets such … Continue reading Mycoplasma Testing Market by Product & Services, Technique, Application and End User – 2022

The global glycomics market was USD 649.5 Million in 2016 | Dominated By North America

The key players in the glycomics market¬†include Agilent Technologies (U.S.), Bruker Corporation (U.S.), Danaher Corporation (U.S.), New England Biolabs (U.S.), ProZyme, Inc. (U.S.), Shimadzu Corporation (Japan), Merck KGaA (Germany), Takara Bio, Inc. (Japan), Thermo Fisher Scientific (U.S.), and Waters Corporation (U.S.). Factors such as increasing government and private funding for glycomics and proteomics research and … Continue reading The global glycomics market was USD 649.5 Million in 2016 | Dominated By North America